

% ======================================================================
% == Appendices for Chapter 1
% ======================================================================

\section{Chapter 1 Supplementary}
\label{apdx:supplemental}


% == Figures and Tables ================================================
\subsection{Figures \& Tables}
\label{subapdx:figtabs}
\newpage



% ## Tab S1
{\footnotesize
    \begin{longtable}{|p{1.5cm}|p{1cm}|p{1cm}|p{1cm}|p{2cm}|p{6cm}|p{1.7cm}|}
        \caption{
            lorem ipsum dolor sit amet consectetur adipiscing elit sed do
            eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
            veniam quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
            commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
            esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
        } \label{tab:your_label_here} \\
        
        \hline
        \textbf{Cell Type} & \textbf{Donor / Line} & \textbf{Donor Ages} & \textbf{Donor Sex} & \textbf{Date of negative Mycoplasma test} & \textbf{Experiment(s)}                                                                                   & \textbf{Figures}   \\
        \hline

        \endfirsthead

        \multicolumn{7}{c}%
        {\tablename\ \thetable\ -- \textit{Continued from previous page}}                                                                                                                                                                                                 \\
        \hline
        \textbf{Cell Type} & \textbf{Donor / Line} & \textbf{Donor Ages} & \textbf{Donor Sex} & \textbf{Date of negative Mycoplasma test} & \textbf{Experiment(s)}                                                                                   & \textbf{Figures}   \\
        \hline

        \endhead

        \hline \multicolumn{7}{r}{\textit{Continued on next page}}                                                                                                                                                                                                        \\
        \endfoot
        \endlastfoot
        Myeloma Cell Line  & INA-6                 & 80                  & m                  & 09.02.22                                  & All                                                                                                      & All                \\
                           & U266                  &                     &                    & 10.10.22                                  & - Validation of V-Well Adhesion Assay                                                                    & S1E                \\
                           & MM1.S                 &                     &                    & 24.02.22                                  &                                                                                                          &                    \\
        hMSC               & 1639                  & 49                  & m                  & not tested                                & - Validation of V-Well Adhesion Assay                                                                    & S1E                \\
                           &                       &                     &                    &                                           & - Time-lapse: INA-6 on dispersed hMSC                                                                    & 1D; 2[A-E]         \\
                           & 1571                  & 72                  & m                  & not tested                                & - Saturation of hMSCs                                                                                    & 1[A-B]             \\
                           & 1573                  & 47                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1578                  & 82                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1842                  & 63                  & m                  & not tested                                & - INA-6 Viability dep. on time and hMSC adhesion surface (INA not washed off)                            & 1E right           \\
                           & 1843                  & 60                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1537                  & 77                  & f                  & not tested                                &                                                                                                          &                    \\
                           & 1794                  & 82                  & m                  & not tested                                & - INA-6 Viability dep. on time and hMSC adhesion surface (INA washed off)                                & 1[C, E left]       \\
                           & 1779                  & 61                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1849                  & 69                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1854                  & 80                  & f                  & not tested                                &                                                                                                          &                    \\
                           & 1605                  & 71                  & f                  & not tested                                & - Time-lapse: INA-6 on dispersed hMSC                                                                    & 1D; 2[A-E]         \\
                           & 1650                  & 57                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1859                  & 64                  & f                  & not tested                                & - Time-lapse: INA-6 on confluent hMSC                                                                    & 2[G-I]             \\
                           & 1863                  & 79                  & f                  & not tested                                &                                                                                                          &                    \\
                           & 1861                  & 52                  & f                  & not tested                                &                                                                                                          &                    \\
                           & 1818                  & 81                  & f                  & not tested                                & - Cell Cycle Profiling after V-well assay                                                                & 3C                 \\
                           & 1824                  & 82                  & f                  & not tested                                & (Donor measured twice, different passages)                                                               &                    \\
                           &                       &                     &                    &                                           & - V-well adhesion assay of mitotically blocked INA-6 followed by Cell Cycle Profiling after V-well assay & 3[B,C]             \\
                           & 1827                  & 56                  & m                  & not tested                                & - V-well adhesion assay of mitotically blocked INA-6 followed by Cell Cycle Profiling after V-well assay &                    \\
                           & 1501                  & 59                  & m                  & not tested                                & - INA-6 AI-assisted count during WPSC (INA-6 stained with celltracker green)                             & 4B                 \\
                           & 1643                  & 75                  & f                  & not tested                                &                                                                                                          &                    \\
                           & 1718                  & 67                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1720                  & 58                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1653                  & 65                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1591                  & 78                  & m                  & not tested                                & - WPSC (MACS) followed by RNAseq, Metascape analysis and qPCR validation                                 & 4[A,C,D,E]; 5[A-C] \\
                           &                       &                     &                    &                                           & - WPSC (Wash) followed by qPCR-Validation and Luminescent Viability assays                               & 4[C-E], 4F         \\
                           & 1654                  & 74                  & m                  & not tested                                & - WPSC (MACS) followed by RNAseq, Metascape analysis and qPCR validation                                 & 4[A,C,D,E]; 5[A-C] \\
                           &                       &                     &                    &                                           & - WPSC (Wash) followed by qPCR-Validation and Luminescent Viability assays                               & 4[C-E], 4F         \\
                           & 1655                  & 78                  & f                  & not tested                                & - WPSC (MACS) followed by RNAseq, Metascape analysis and qPCR validation                                 & 4[A,C,D,E]; 5[A-C] \\
                           & 1668                  & 80                  & f                  & not tested                                &                                                                                                          &                    \\
                           & 1670                  & 66                  & f                  & not tested                                &                                                                                                          &                    \\
                           & 1701                  & 81                  & m                  & not tested                                & - WPSC (Wash) followed by qPCR-Validation and Luminescent Viability assays                               & 4[C-E], 4F         \\
                           & 1702                  & 79                  & f                  & not tested                                &                                                                                                          &                    \\
                           & 1600                  & 77                  & m                  & not tested                                &                                                                                                          &                    \\
                           & 1681                  & 56                  & m                  & not tested                                & - WPSC (Wash) followed by Luminescent Viability assays                                                   & 4F                 \\
                           & 1672                  & 65                  & m                  & not tested                                & - WPSC (Wash) followed by qPCR-Validation                                                                & 4[C-E]             \\
        \hline
    \end{longtable}}



% ## Example of including Figures
% > \includeimage[scale][left bottom right top]{
% >     path/to/picture.pdf/.png/.jpg
% > }{caption}{label}


% ## Fig. S1
\includeimage[0.99][{\fmleft} 1.8in {\fmright} {\fmtop}]{
    APPENDIX_CHAPTER1/figures8_supplemental1.pdf
}{
    lorem ipsum dolor sit amet consectetur adipiscing elit sed do
    eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
    veniam quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
    commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
    esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
}{fig:S1}
\newpage

% ## Fig. S2
\includeimage[0.97][{\fmleft} {\fmbottom} {\fmright} {\fmtop}]{
    APPENDIX_CHAPTER1/figures8_supplemental2.pdf
}{
    lorem ipsum dolor sit amet consectetur adipiscing elit sed do
    eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
    veniam quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
    commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
    esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
}{fig:S2}
\newpage

% ## Fig. S3
\includeimage[0.99][{\fmleft} {\fmbottom} {\fmright} {\fmtop}]{
    APPENDIX_CHAPTER1/figures8_supplemental3.pdf
}{
    lorem ipsum dolor sit amet consectetur adipiscing elit sed do
    eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
    veniam quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
    commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
    esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
}{fig:S3}
\newpage

% ## Fig. S4
\includeimage[0.98][{.95\fmleft} {\fmbottom} {\fmright} {\fmtop}]{
    APPENDIX_CHAPTER1/figures8_supplemental4.pdf
}{
    lorem ipsum dolor sit amet consectetur adipiscing elit sed do
    eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
    veniam quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
    commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
    esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
}{fig:S4}
\newpage

% ## Fig. S5
\includeimage[1][{\fmleft} {\fmbottom} {\fmright} {\fmtop}]{
    APPENDIX_CHAPTER1/figures8_supplemental5.pdf
}{
    lorem ipsum dolor sit amet consectetur adipiscing elit sed do
    eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
    veniam quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
    commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
    esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
}{fig:S5}
\newpage


% ## Fig. S6
\includeimage[1][{\fmleft} {\fmbottom} {\fmright} {\fmtop}]{
    APPENDIX_CHAPTER1/figures8_supplemental6.pdf
}{
    lorem ipsum dolor sit amet consectetur adipiscing elit sed do
    eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
    veniam quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
    commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
    esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
}{fig:S6}
\newpage




% == Supplementary Materials and Methods ===============================
\subsection{Materials \& Methods}
\label{subapdx:materialsmethods}
Lorem ipsum dolor

\newpage



% Referenzen als Fu√ünoten ab hier?